Molecular Excipient

305.0 6.5 0 0 4.0 15 0.76
Present in 70 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
ACHE Acetylcholinesterase Enzyme / Enzyme-Other
ADRA2B Alpha-2B adrenergic receptor Membrane Receptor / Gpcr-A
CHRM4 Muscarinic acetylcholine receptor M4 Membrane Receptor / Gpcr-A
HTR2B 5-hydroxytryptamine receptor 2B Membrane Receptor / Gpcr-A
ADRA2C Alpha-2C adrenergic receptor Membrane Receptor / Gpcr-A
CHRM2 Muscarinic acetylcholine receptor M2 Membrane Receptor / Gpcr-A
CHRM3 Muscarinic acetylcholine receptor M3 Membrane Receptor / Gpcr-A
HTR2C 5-hydroxytryptamine receptor 2C Membrane Receptor / Gpcr-A
CHRM5 Muscarinic acetylcholine receptor M5 Membrane Receptor / Gpcr-A
MC4R Melanocortin receptor 4 Membrane Receptor / Gpcr-A
CHRM1 Muscarinic acetylcholine receptor M1 Membrane Receptor / Gpcr-A
HTR2A 5-hydroxytryptamine receptor 2A Membrane Receptor / Gpcr-A
ADORA3 Adenosine receptor A3 Membrane Receptor / Gpcr-A
TACR2 Substance-K receptor Membrane Receptor / Gpcr-A
ADRA2A Alpha-2A adrenergic receptor Membrane Receptor / Gpcr-A
MC5R Melanocortin receptor 5 Membrane Receptor / Gpcr-A
HTR1A 5-hydroxytryptamine receptor 1A Membrane Receptor / Gpcr-A
LCK Proto-oncogene tyrosine-protein kinase LCK Enzyme / Kinase
FYN Tyrosine-protein kinase Fyn Enzyme / Kinase
EGFR Epidermal growth factor receptor Enzyme / Kinase
ERBB2 Receptor tyrosine-protein kinase erbB-2 Enzyme / Kinase
TBXAS1 Thromboxane-A synthase Enzyme / P450
SLC6A2 Sodium-dependent noradrenaline transporter Transporter / Electrochemical-Transporter
SLC6A4 Sodium-dependent serotonin transporter Transporter / Electrochemical-Transporter
SLC6A3 Sodium-dependent dopamine transporter Transporter / Electrochemical-Transporter

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT02297997 2014-11-01 Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy Phase 0 Enrolling By Invitation
NCT02193165 2014-07-01 The Clinical Efficacy of Three Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Dental Plaque and Gingivitis Phase 3 Completed
NCT02360995 2014-06-01 The Clinical Investigation of Toothpaste as Compared to Toothpaste and Mouthwash in Reducing Plaque and Gingivitis: A Six-week Clinical Study in the US Phase 4 Completed
NCT02366689 2014-06-01 Clinical Study Comparing Dental Plaque and Gingivitis Reduction After Using One of Three Oral Hygiene Multi-component Regimens (Using of a Manual Toothbrush, a Toothpaste and a Mouthwash) Phase 4 Completed
NCT00729599 2008-07-01 Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen. Phase 3 Completed
NCT00687037 2008-01-01 Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power Phase 3 Completed

(Browse) Purchasable Analogs in ZINC


Route Formulation Per Unit Dose
Inhalation Aerosol, Metered
Inhalation Aerosol, Spray
Iontophoresis Drug Delivery System 1.2MG
Oral Aerosol, Metered
Oral Capsule 1.5MG
Oral Capsule, Soft Gelatin 0.004MG
Oral Capsule, Sustained Action 0.02MG
Transdermal Drug Delivery System 1.2MG

More Information

Usage Over Time